Literature DB >> 266735

Inhibition by anti-interferon serum of lymphocytic choriomeningitis virus disease in suckling mice.

Y Rivière, I Gresser, J C Guillon, M G Tovey.   

Abstract

Inoculation of newborn mice with lymphocytic chloriomeningitis (LCM) virus resulted in decreased weight gain, liver cell necrosis, and death. Injection of potent sheep immunoglobulin against mouse interferon markedly inhibited these manifestations of LCM virus disease despite the fact that these treated mice had 100-fold more LCM virus in their serum. We conclude that interferon induced by LCM virus is responsible in large part for the syndrome of growth inhibition, liver cell necrosis, and death observed in LCM virus-infected suckling mice.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 266735      PMCID: PMC431090          DOI: 10.1073/pnas.74.5.2135

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  EXPERIMENTS ON HETEROLOGOUS AND HOMOLOGOUS INTERFERENCE IN LCM-INFECTED CULTURES OF MURINE LYMPH NODE CELLS.

Authors:  E TRAUB; F KESTING
Journal:  Arch Gesamte Virusforsch       Date:  1963-10-07

2.  The biology of lymphocytic choriomeningitis infection: virus-induced immune disease.

Authors:  J HOTCHIN
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1962

3.  Lymphocytic choriomeningitis infection of mice as a model for the study of latent virus infection.

Authors:  J E HOTCHIN; M CINITS
Journal:  Can J Microbiol       Date:  1958-04       Impact factor: 2.419

4.  Efficacy of exogenous interferon treatment initiated after onset of multiplication of vesicular stomatitis virus in the brains of mice.

Authors:  I Gresser; M G Tovey; C Bourali-Maury
Journal:  J Gen Virol       Date:  1975-06       Impact factor: 3.891

5.  Progressive glomerulonephritis in mice treated with interferon preparations at birth.

Authors:  I Gresser; C Maury; M Tovey; L Morel-Maroger; F Pontillon
Journal:  Nature       Date:  1976-09-30       Impact factor: 49.962

6.  Effects of interferon on antibody synthesis in vitro.

Authors:  R H Gisler; P Lindahl; I Gresser
Journal:  J Immunol       Date:  1974-08       Impact factor: 5.422

7.  Suppression of mouse antibody producing spleen cells by various interferon preparations.

Authors:  T J Chester; K Paucker; T C Merigan
Journal:  Nature       Date:  1973-11-09       Impact factor: 49.962

8.  Priming: a nonantiviral function of interferon.

Authors:  W E Stewart; L B Gosser; R Z Lockart
Journal:  J Virol       Date:  1971-06       Impact factor: 5.103

9.  Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum. II. Studies with herpes simplex, Moloney sarcoma, vesicular stomatitis, Newcastle disease, and influenza viruses.

Authors:  I Gresser; M G Tovey; C Maury; M T Bandu
Journal:  J Exp Med       Date:  1976-11-02       Impact factor: 14.307

10.  Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum. I. Rapid evolution of encephalomyocarditis virus infection.

Authors:  I Gresser; M G Tovey; M E Bandu; C Maury; D Brouty-Boyé
Journal:  J Exp Med       Date:  1976-11-02       Impact factor: 14.307

View more
  25 in total

1.  Interferon treatment of NZB mice: accelerated progression of autoimmune disease.

Authors:  H Heremans; A Billiau; A Colombatti; J Hilgers; P de Somer
Journal:  Infect Immun       Date:  1978-09       Impact factor: 3.441

2.  Genetic reassortants of lymphocytic choriomeningitis virus: unexpected disease and mechanism of pathogenesis.

Authors:  Y Riviere; M B Oldstone
Journal:  J Virol       Date:  1986-08       Impact factor: 5.103

3.  Role of interferon in mice in protection against influenza A virus by bacterial ribosomes together with membranal glycoproteins of Klebsiella pneumoniae as adjuvant.

Authors:  D Robert; J P Quillon; B Ivanoff; Y Beaudry; R Fontanges; G Normier; A M Pinel; L D D'hinterland
Journal:  Infect Immun       Date:  1979-11       Impact factor: 3.441

4.  A Brief Historical Perspective on the Pathological Consequences of Excessive Type I Interferon Exposure In vivo.

Authors:  Yanick J Crow; Pierre Lebon; Jean-Laurent Casanova; Ion Gresser
Journal:  J Clin Immunol       Date:  2018-09-05       Impact factor: 8.317

5.  Mechanisms of enhanced resistance of Mycobacterium bovis BCG-treated mice to ectromelia virus infection.

Authors:  T Sakuma; T Suenaga; I Yoshida; M Azuma
Journal:  Infect Immun       Date:  1983-11       Impact factor: 3.441

Review 6.  Expression of the genes of interferons and other cytokines in normal and diseased tissues of man.

Authors:  M G Tovey
Journal:  Experientia       Date:  1989-06-15

7.  Resistance of lymphocytic choriomeningitis virus to alpha/beta interferon and to gamma interferon.

Authors:  D Moskophidis; M Battegay; M A Bruendler; E Laine; I Gresser; R M Zinkernagel
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

8.  Electrophoretically pure mouse interferon inhibits growth, induces liver and kidney lesions, and kills suckling mice.

Authors:  I Gresser; M Aguet; L Morel-Maroger; D Woodrow; F Puvion-Dutilleul; J C Guillon; C Maury
Journal:  Am J Pathol       Date:  1981-03       Impact factor: 4.307

9.  Hypoglycemia in mice injected with interferon inducers is not mediated by interferon.

Authors:  F Vignaux; I Gresser
Journal:  Infect Immun       Date:  1981-08       Impact factor: 3.441

10.  Delay in growth and the development of nephritis in rats treated with interferon preparations in the neonatal period.

Authors:  I Gresser; L Morel-Maroger; F Châtelet; C Maury; M Tovey; M T Bandu; J Buywid; M Delauche
Journal:  Am J Pathol       Date:  1979-05       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.